Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Visiolight
- Development stage
- Unknown
- Lead developer
- Spey Medical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Visiolight is a multi-ingredient dietary supplement developed by SPEY to support eye health and prevent visual impairment. Formulated as an oral tablet, it contains a high dose of natural lutein (25 mg) and zeaxanthin, which accumulate in the macula and act as natural filters for blue light. The formulation is enriched with essential vitamins (C, E, B1, B2, B6, B12, and beta-carotene), minerals (zinc and selenium), and botanical extracts (bilberry and grape seed). Together, these components provide robust antioxidant protection, shielding ocular cells from oxidative stress and reducing visual fatigue associated with prolonged screen exposure, reading under artificial light, or driving.
- Brand names
- VisiolightVisiolight KidsVisiolight Lutein
- Other names
- ВизиолайтВизиолайт КидсВизиолайт Лютеин
Beyond the preview
Go deeper on Visiolight.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Visiolight.